ISE-SMNE Webinar: ApoCIII and ANGPTL3 as Therapeutic Targets

Join us for our first webinar of the year in partnership with the Mexican Society of Nutrition and Endocrinology (SMNE) on Wednesday, 11 February 2026, 3pm (CET) / 8am (CDMX).

Learn from leading experts, Dr. Carlos A. Aguilar Salinas and Dr. Daniel Elías López, both from Mexico, to explore how emerging science around ApoCIII and ANGPTL3 is transforming our understanding of triglyceride metabolism which will involve unpacking the unique lipid patterns driving cardiovascular risk and examining how novel inhibitors of ApoCIII and ANGPTL3 are reshaping treatment strategies.

Recent evidence highlights the central role of these proteins in regulating triglyceride rich lipoproteins and remnant cholesterol – key contributors to atherosclerotic cardiovascular disease. With innovative therapies now emerging, these targets represent one of the most exciting frontiers in lipid management.

Moderated by Dr. Roopa Mehta (Mexico), this webinar will equip clinicians with:

1. Practical, evidence based insights to better identify dyslipidemia patterns
2. Understanding on the molecular pathways behind atherogenic triglycerides
3. New therapeutic approaches that may be implemented in real world healthcare settings.

Please note that this webinar will be conducted in Spanish. However, live interpretation to English will also be made available.